CSI Market
Sign In | Register

Viropharma Inc (VPHM) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access VPHM quarterly Cash Flow →
Quarterly cash flow trends provide additional context on Viropharma Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2012)
12 Months 		(Dec 31 2009) (Dec 31 2012)
Operating Activities
Income5.61
Depreciation & amortization37.82
Amortization of Other Assets44.58
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories3.25
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation23.13
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability4.48
Gain On Long Term Debt Repurchase-
Deferred Income Tax Noncash Expense Benefit-20.71
Income taxes-34.04
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-4.21
Increase (Decrease) in Accounts Payable9.30
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities4.14
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets5.24
Other Working Capital15.50
Other Noncash Income (Expense)3.57
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities43.02
Investing Activities
Capital Expenditures-1.33
Sale of Capital Items0.00
Short-term Investments Proceeds55.56
Short-term Investments Acq.0.00
Real Estate Investments0.00
Contingent Consideration Payments To Acquire Intangible Assets-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Business Three, Net of Cash Acquired-92.27
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-38.05
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-168.38
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net7.12
Other net0.00
Payment Of Contingent Consideration Financing-
Termination Of Call Spread Options-
Share Repurchase Forward Contract-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-161.27
Effect of exchange rate on cash flow0.47
Discontinued operations0.00
Free Cash Flow41.68
Total Cash Flow-155.83
4 historic quarters locked

Sign in to unlock the full Viropharma Inc cash flow history.

Sign In Create Free Account

About VPHM Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License